NCT04725500View on ClinicalTrials.gov

Vector Engineering Clinical

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 4, 2018

Primary Completion Date

March 3, 2020

Study Completion Date

March 3, 2020

Conditions
COPD
Interventions
DEVICE

Auto-Titrating EPAP

In the Auto-titrating EPAP mode, the device automatically adjusted EPAP to the minimum level able to abolish tidal expiratory flow limitation.

Trial Locations (2)

15025

Jefferson Associates and Internal Medicine, Clairton

44512

Pulmonary Rehabilitation Associates, Youngstown

All Listed Sponsors
lead

Philips Clinical & Medical Affairs Global

INDUSTRY

NCT04725500 - Vector Engineering Clinical | Biotech Hunter | Biotech Hunter